New Delhi, Jan 3 The Central Licensing Authority on Sunday granted permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution, after the indigenous coronavirus vaccine received regulatory approval for emergency use.
"The Central Licensing Authority has granted permission to Bharat Biotech International Ltd to manufacture for sale of the pharmaceutical formulation," a top source told .
Earlier on Sunday, Drug Controller General of India
( With inputs from IANS )
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor